Technical Analysis for KPTI - Karyopharm Therapeutics Inc.

Grade Last Price % Change Price Change
C 0.90 -8.75% -0.09
KPTI closed down 8.75 percent on Friday, November 1, 2024, on 2.22 times normal volume.
Earnings due: Nov 5
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
200 DMA Resistance Bearish -8.75%
Crossed Above 20 DMA Bullish -8.75%
MACD Bullish Signal Line Cross Bullish -8.75%
Expansion Breakout Bullish Swing Setup -8.75%
Pocket Pivot Bullish Swing Setup -8.75%
Volume Surge Other -8.75%
Wide Range Bar Range Expansion -8.75%

   Recent Intraday Alerts

Alert Time
Down 5% about 16 hours ago
Down 1 ATR about 16 hours ago
60 Minute Opening Range Breakdown about 16 hours ago
Up 3% about 17 hours ago
Possible Inside Day about 18 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Karyopharm Therapeutics Inc. Description

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. The company's lead drug candidate includes Selinexor, an oral selective inhibitors of nuclear export (SINE) compound that specifically blocks XPO1 cargo binding is in Phase I clinical trials in patients with heavily pretreated relapsed and/or refractory hematological and solid tumor malignancies. Its other drug candidates comprise KPT-350 and related SINE compounds; PAK4 inhibitors; and Verdinexor, a SINE compound that is in Phase IIb clinical trials in pet dogs with newly-diagnosed or first relapse after chemotherapy lymphomas. The company was founded in 2008 and is based in Natick, Massachusetts.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Pharmaceutical Disease Treatment Of Cancer Oncology Chemotherapy Lymphoma Occupational Safety And Health Dog Stage Pharmaceutical Antibody Drug Conjugate

Is KPTI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.95
52 Week Low 0.6174
Average Volume 767,767
200-Day Moving Average 1.02
50-Day Moving Average 0.80
20-Day Moving Average 0.86
10-Day Moving Average 0.87
Average True Range 0.07
RSI (14) 55.56
ADX 33.96
+DI 33.51
-DI 5.69
Chandelier Exit (Long, 3 ATRs) 0.91
Chandelier Exit (Short, 3 ATRs) 1.03
Upper Bollinger Bands 0.93
Lower Bollinger Band 0.79
Percent B (%b) 0.8
BandWidth 16.64
MACD Line 0.02
MACD Signal Line 0.02
MACD Histogram 0.0056
Fundamentals Value
Market Cap 103.45 Million
Num Shares 115 Million
EPS -1.31
Price-to-Earnings (P/E) Ratio -0.69
Price-to-Sales 1.19
Price-to-Book 12.05
PEG Ratio -0.15
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.11
Resistance 3 (R3) 1.13 1.07 1.08
Resistance 2 (R2) 1.07 1.02 1.07 1.07
Resistance 1 (R1) 0.99 0.99 0.96 0.97 1.05
Pivot Point 0.93 0.93 0.92 0.93 0.93
Support 1 (S1) 0.85 0.88 0.82 0.83 0.75
Support 2 (S2) 0.79 0.85 0.79 0.74
Support 3 (S3) 0.71 0.79 0.73
Support 4 (S4) 0.69